Gene · 406949
Papers3,765
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 3,765
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Systematic review of circulating MICRORNAS as biomarkers of cervical carcinogenesis. | BMC Cancer | 2022 | 35933332 | PubTator, text mining | PubMed |
| The functions of long noncoding RNAs on regulation of F-box proteins in tumorigenesis and progression. | Front Oncol | 2022 | 35928868 | PubTator, text mining | PubMed |
| The emerging role of miRNAs in the pathogenesis of COVID-19: Protective effects of nutraceutical polyphenolic compounds against SARS-CoV-2 infection. | Int J Med Sci | 2022 | 35928726 | PubTator, text mining | PubMed |
| Light Emitting Diodes Irradiation Regulates miRNA-877-3p to Promote Cardiomyocyte Proliferation. | Int J Med Sci | 2022 | 35928721 | PubTator, text mining | PubMed |
| Identification of differentially expressed microRNAs as potential biomarkers for carcinoma ex pleomorphic adenoma. | Sci Rep | 2022 | 35927424 | PubTator, text mining | PubMed |
| The Key Role of microRNAs in Initiation and Progression of Hepatocellular Carcinoma. | Front Oncol | 2022 | 35924150 | PubTator, text mining | PubMed |
| Susceptibility genes of hyperuricemia and gout. | Hereditas | 2022 | 35922835 | PubTator, text mining | PubMed |
| Recent insights into the microRNA-dependent modulation of gliomas from pathogenesis to diagnosis and treatment. | Cell Mol Biol Lett | 2022 | 35922753 | PubTator, text mining | PubMed |
| lncRNA MALAT1 Promotes Diabetic Nephropathy Progression via miR-15b-5p/TLR4 Signaling Axis. | J Immunol Res | 2022 | 35910856 | PubTator, text mining | PubMed |
| Possible relation between expression of circulating microRNA and plasma cytokine levels in cases of pulmonary tuberculosis. | J Infect Dev Ctries | 2022 | 35905021 | PubTator, text mining | PubMed |
| Altered Expressions of Transfer RNA-Derived Small RNAs and microRNAs in the Vitreous Humor of Proliferative Diabetic Retinopathy. | Front Endocrinol (Lausanne) | 2022 | 35903272 | PubTator, text mining | PubMed |
| A Glycosyltransferase-Related Signature for Predicting Overall Survival in Head and Neck Squamous Cell Carcinoma. | Front Genet | 2022 | 35899200 | PubTator, text mining | PubMed |
| Promising Biomarkers in Head and Neck Cancer: The Most Clinically Important miRNAs. | Int J Mol Sci | 2022 | 35897831 | PubTator, text mining | PubMed |
| Performance of Salivary Extracellular RNA Biomarker Panels for Gastric Cancer Differs between Distinct Populations. | Cancers (Basel) | 2022 | 35892889 | PubTator, text mining | PubMed |
| MicroRNAs as Potential Tools for Predicting Cancer Patients' Susceptibility to SARS-CoV-2 Infection and Vaccination Response. | Cells | 2022 | 35892576 | PubTator, text mining | PubMed |
| Sequence-Specific Features of Short Double-Strand, Blunt-End RNAs Have RIG-I- and Type 1 Interferon-Dependent or -Independent Anti-Viral Effects. | Viruses | 2022 | 35891387 | PubTator, text mining | PubMed |
| Identification of MiRNA-Disease Associations Based on Information of Multi-Module and Meta-Path. | Molecules | 2022 | 35889314 | PubTator, text mining | PubMed |
| Skin Cancer Research Goes Digital: Looking for Biomarkers within the Droplets. | J Pers Med | 2022 | 35887633 | PubTator, text mining | PubMed |
| MicroRNAs as Potential Biomarkers in the Differential Diagnosis of Lipomatous Tumors and Their Mimics. | Int J Mol Sci | 2022 | 35887151 | PubTator, text mining | PubMed |
| Emerging Roles and Potential Applications of Non-Coding RNAs in Cervical Cancer. | Genes (Basel) | 2022 | 35886037 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406949/papers?page=34